F. Muggia, P. Creaven, H. Hansen, M. Cohen and O. Selawry, “Phase I Clinical Trial of Weekly and Daily Treatment with Camptothecin (NSC-100880): Correlation with Preclinical Studies,” Cancer Chemotherapy Reports, Vol. 56, No. 4, 1972, pp. 515-521.

has been cited by the following article:

• TITLE: Sulfuric Acid Catalyzed Preparation of Alkyl and Alkenyl Camptothecin Ester Derivatives and Antitumor Activity against Human Xenografts Grown in Nude Mice

  AUTHORS: Zhisong Cao, Anthony Kozielski, Dana Vardeman, Beppino Giovanella

  KEYWORDS: Anti-Cancer Drugs; Activity; Esterification; Camptothecin; 9-Nitrocamptothecin

  JOURNAL NAME: Open Journal of Medicinal Chemistry, Vol.2 No.1, March 28, 2012

  ABSTRACT: Camptothecin-20-propinate (CZ48) and other camptothecin ester derivatives were prepared by the esterification reac-tions of camptothecin or 9-nitrocamptothecin with the corresponding acylating agents such as organic acid anhydride or chloride with concentrate sulfuric acid as the catalyst. The sulfuric acid-catalyzed reactions gave high yields of camptothecin ester products.Among the 11 compounds prepared by this method, camptothecin-20-O-propionate, camptothecin-20-O-crotonate, and 9-nitrocamptothecin-20-O-propionate showed good anticancer activity against various types of human tumors grown as xenografts in nude mice. The methodology developed for the preparation of camptothecin esters in this article can be applied to a wide scope of other ester derivatives.